Tomek Dabrowski

reimagining healthcare. Scaling Up healthcare companies. CEO Humaneva Group | Pratia | Kapadi | Hyggio

[Tomek Dabrowski @tdabrowsky]

How GSK’s Silicon Valley veteran transformed the pharma giant into a tech powerhouse | Fortune Europe https://t.co/RZXJu4N226

[Tomek Dabrowski @tdabrowsky]

Global mental health crisis hits workplaces
https://t.co/DoFtwvxUyp

[Tomek Dabrowski @tdabrowsky]

Trump picks Johns Hopkins researcher Marty Makary to lead the FDA https://t.co/cYH5mTHkvr

[Tomek Dabrowski @tdabrowsky]

Globalny inwestor wyśle Humanevę w świat. Polska firma z przełomową szansą https://t.co/tmtTR4UQ50

[Tomek Dabrowski @tdabrowsky]

French biotech Generare speeds up hunt for new drugs by cloning natural molecules | TechCrunch https://t.co/1DdmUWC530

[Tomek Dabrowski @tdabrowsky]

Bluesky continues to soar, adding 2M more new users in a matter of days | TechCrunch https://t.co/Gp3pa3VKEK

[Andrew D. Huberman, Ph.D. @hubermanlab]

The data on how to study and learn indicate that tests, in particular self-tests done very soon after learning new material, are among the most effective tools to offset forgetting. Tests are key for both learning & evaluation. https://t.co/yiflouY9w0

[Tomek Dabrowski @tdabrowsky]

After an FDA rejection, here’s what’s next in the psychedelics pipeline | BioPharma Dive https://t.co/mN9HhtwzbX

[Tomek Dabrowski @tdabrowsky]

Pressure from anti-China legislation begins to ripple through biopharma https://t.co/KptaE1Yfnx

[Tomek Dabrowski @tdabrowsky]

Genentech, Gilead push FDA to modernize research inspections https://t.co/ktbWLSgc5f

[Tomek Dabrowski @tdabrowsky]

Hello, neffy: FDA approves first nasal spray for severe allergic reactions https://t.co/LgtrAdp0ng

[Tomek Dabrowski @tdabrowsky]

Lykos’ MDMA-assisted PTSD treatment rejected by FDA after troubled trial and pushback from experts https://t.co/ptRRrgtIf7

[Tomek Dabrowski @tdabrowsky]

First Patients Enrolled in US Pivotal Study of AI-Based Image Analysis Module for Lung Cancer - https://t.co/JYaS8PXbLX MedNews https://t.co/legkTtiQjL

[Tomek Dabrowski @tdabrowsky]

WuXi Bio gains some traction in Europe in the face of Biosecure threat in the US https://t.co/L2VczSWIv8

[Tomek Dabrowski @tdabrowsky]

Sarclisa Combination Produces Significantly Improved Progression-Free Survival in Newly Diagnosed Multiple Myeloma https://t.co/DbA7Hsq8Ed

[Tomek Dabrowski @tdabrowsky]

Compounded weight loss drugs have resulted in misdosing, hospitalizations, FDA warns https://t.co/FR7dSeJjQb

[Tomek Dabrowski @tdabrowsky]

European drug regulator rejects Alzheimer's drug Leqembi, citing safety concerns https://t.co/6Q2EwT64sm

[Tomek Dabrowski @tdabrowsky]

Taking advantage of recent successes, Roche will push obesity drugs faster, flirts with M&A https://t.co/G0JFN1qJoI

[Tomek Dabrowski @tdabrowsky]

Private biotech M&A surges amid difficult IPO market https://t.co/gKBgB5UBji

[Tomek Dabrowski @tdabrowsky]

Agilent Technologies to acquire CDMO Biovectra for $925M https://t.co/HE6gcy0o1R